Alzheimer Disease
Alzheimer's drug based on Purdue -- designed inhibitor begins clinical trials
Published in Drug Week, July 6th, 2007
"Millions of people suffer from this devastating disease and treatment options are very limited," said Arun Ghosh, the Purdue professor who led the creation of the treatment molecule. "Current drugs manage the symptoms, but this could be the first disease-modifying therapy. It may be able to prevent and reverse the disease."
CoMentis Inc., a biopharmaceutical company based in San Francisco, is initiating the clinical trials of the experimental drug CTS-21166. Ghosh, who has dual appointments in the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-07-06)
More Articles from Drug Week
- Adverse Drug Reactions
Long-term etanercept treatment reduces psoriasis severity without increased adverse events - Angiotensins
Medicare Part D plans vary, but most appear to cover common medications at low co-payments - Ankylosing Spondylitis
Remicade data in ankylosing spondylitis show improvement in spinal mobility and spinal inflammation - Arthritis
Increased alcohol intake associated with decreased risk of developing rheumatoid arthritis - Attention Deficit Hyperactivity Disorder
Does Stimulant Treatment for ADHD Increase Risk of Drug Abuse? - Biomedical Engineering
Papers of Medical Philanthropist and NIH Benefactor Mary Lasker Added to the National Library - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
